Tioopo Capital, in partnership with SPE Capital, announces the acquisition of Oury Guye & Fils, a century-old company in medical devices, French Fab member and labelled Entreprise du Patrimoine Vivant.
Founded in 1909 in Nogent (Haute-Marne), Oury-Guyé has established its position in orthopedic and ancillary instrumentation, counting the largest orthopedic groups as customers in France and abroad.
A century of medical excellence
For more than 110 years, Oury Guye & Fils has been a quiet but essential player in surgical instrumentation. Operating from Nogent, France's historic capital of cutlery and surgical instrument craftsmanship, the company combines artisanal precision with industrial reliability.
Its customers include the world's leading orthopedic manufacturers, who rely on Oury Guye's instruments and ancillaries to support the most demanding surgical procedures.
The platform investment
This acquisition serves as the platform for a broader buy-and-build strategy in surgical instrumentation. The investment thesis: combine Oury Guye's century of credibility with complementary expertise in cutting tools, sheet metal containers, and R&D-driven implant design to create a unique European partner for orthopedic instrumentation.
The strategy has since unfolded through three add-on acquisitions: SMAO (Jan 2023), MGC (Oct 2023), and Imprint Medical (Nov 2023), together forming the Oury Medical group.